Study of MCLA-129 in Combination With Ensartinib in Patients With Advanced Solid Tumors.
Study of MCLA-129 in Combination With Ensartinib in Patients With Advanced Solid Tumors.
Recruiting · NCT07448116 · Registry updated 2026-03-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of MCLA-129 in Combination With Ensartinib in Patients With Advanced Solid Tumors. | Solid Advanced Tumor | Recruiting | Phase 1 / Phase 2 | 2026-03-04 | NCT07448116 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Betta Pharmaceuticals Co., Ltd. | 20 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Hospital Chinese Academy of Medical Sciences | Beijing | China | 71 |